PREDICTION-ADR
Personalisation of tREatment In Cardiovascular disease through next generation sequencing in Adverse Drug Reactions
| Coordinator | PHARMACOGENOMIC INNOVATIVE SOLUTIONS LIMITED ; ADORIAL TECHNOLOGIES LTD ; Uppsala University ; University of Dundee ; Utrecht University ; Asper Biotech (Estonia) ; University of Liverpool |
| Grant period | 2013-09-01 - 2017-02-28 |
| Funding body | European Union |
| Call number | FP7-HEALTH-2013-INNOVATION-1 |
| Grant number | 602108 |
| Identifier | G:(EU-Grant)602108 |